Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04955717 · ClinicalTrials.gov registry record · NA
Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences
A NA study, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT04955717 is a NA study that has completed, run by University of Southern California. The registered enrollment target is 500 participants.
The verdict
NCT04955717, a NA study, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
To assess the effectiveness of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing and treatment during pregnancy to reduce adverse pregnancy and birth outcomes compared to the standard of care (treatment based on symptoms and signs).
Interventions
- OTHER Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2021-02-24 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04955717
The ClinicalTrials.gov registry entry for NCT04955717 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert is the first listed.
NCT04955717 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04955717 about?
NCT04955717 is a clinical study titled "Antenatal Chlamydia Trachomatis and Neisseria Gonorrhoeae Testing to Prevent Adverse Neonatal Consequences". To assess the effectiveness of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) testing and treatment during pregnancy to reduce adverse pregnancy and birth outcomes compared to the standard of care (treatment based on symptoms and signs).
What is the current status of trial NCT04955717?
This trial is currently completed. It is a NA study. The enrollment target is 500 participants. The study started on 2021-02-24. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT04955717?
The interventions under investigation include: Chlamydia trachomatis and Neisseria gonorrhoeae screening using the GeneXpert (OTHER).
Who is sponsoring clinical trial NCT04955717?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.